Alirocumab in Patients with Sepsis

Summary

The purpose of this study is to determine whether the drug alirocumab, which may lower cholesterol, can reduce the amount of inflammation caused by an infection that has caused either low blood pressure or difficulty breathing. Participants will be randomized to receive a single IV infusion of alirocumab or a placebo.

Timeline

Start

2023-01-04

Primary completion

2025-02-18

Completion

2025-02-23

Drugs

Indications